Open Access
  • 17 November 2026
    • journal article
    • research article
    • Published by MDPI AG in Foods
    • Vol. 15  (22) , 4124
    • DOI:10.3390/foods15224124
Abstract
Myrica rubra wine (MRW) and salted Myrica rubra (SMR) are processed fruit products with poorly defined effects on intestinal inflammation. We examined both products in male C57BL/6J mice with dextran sulfate sodium (DSS)-induced colitis. MRW and SMR were administered daily for seven days before DSS exposure and throughout the seven-day DSS induction period. Clinical outcomes, blood indices, colonic transcripts, and serum and fecal metabolomic profiles were assessed. MRW and SMR reduced body weight loss and disease activity relative to the DSS model group, although neither normalized all measured outcomes. A serum feature set mapped to primary bile acid biosynthesis differed from the model group after both interventions following global false discovery rate correction (both q = 0.0012). This pathway assignment depended on putative metabolite annotations. Features provisionally annotated as glycocholate and taurocholic acid showed higher relative signals, whereas a feature annotated as taurine showed a lower signal. Colonic inflammatory and barrier-related transcripts also changed, with different patterns in MRW and SMR. The exploratory metabolite–phenotype correlations did not survive correction for multiple testing. These findings associate preventive MRW and SMR administration with attenuated clinical signs and changes in features provisionally assigned to bile acid metabolism during DSS-induced colitis. They do not establish efficacy against established colitis or a causal role for bile acids.

This publication has 40 references indexed in Scilit: